SIS
COLL icon

Sound Income Strategies’s Collegium Pharmaceutical COLL Stock Holding History

Sound Income Strategies’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57
Closed -$1.9K – 852
2026
Q1 		$1.9K Hold
57
– – ﹤0.01% 2161
2025
Q4 		$2.6K Buy
+57
New +$2.38K ﹤0.01% 2060

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Sound Income Strategies's COLL Position: Q2 2026 in Review

Sound Income Strategies sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 57 shares — an estimated $1.9K sold.

Sound Income Strategies first reported a position in COLL in Q4 2025 and held it in 2 quarters. The position peaked at $2.6K in Q4 2025. 205 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Sound Income Strategies reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 57 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.9K.
  • Sound Income Strategies first reported a position in Collegium Pharmaceutical in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's Collegium Pharmaceutical position peaked at $2.6K in Q4 2025.
  • 205 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.